Effect of topical Dorzolamide and Latanoprost on Refractio
Phase 2
- Conditions
- glaucoma.Primary open-angle glaucoma
- Registration Number
- IRCT2013052813505N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
all patients with open angle glaucoma; older than 16; with eye pressure of 21 to 30 mm Hg which have not taken any treatment.
Exclusion criteria: previous use of systemic or topical dorsolamide; using contact lens since 1 month ago; taking sulfa drug since 1 month ago; lactation; pregnancy (pregnancy reduce eye pressure and increase cornea thickness); cataract; any kind of eye surgery; CD/disc more than 0.8; best visually by less than 20/40 (with using Pin Hole); any neuropathy, any severe damage to visual field; and also any increase in eye pressure more than 30 mm Hg during the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Refraction. Timepoint: 2 and 6±1weeks. Method of measurement: Autorefractometr.
- Secondary Outcome Measures
Name Time Method Visual acuity, thickness of lens and cornea and depth of anterior chamber. Timepoint: 2 and 6±1weeks. Method of measurement: Visual acuity with Snelen chart, thickness of lens and cornea and depth of anterior chamber by IOL Master.